SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-22-008469
Filing Date
2022-05-09
Accepted
2022-05-09 16:00:46
Documents
14
Period of Report
2022-05-09
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K enta-20220509.htm   iXBRL 8-K 50374
2 EX-99.1 enta-ex99_1.htm EX-99.1 312938
3 GRAPHIC img152620751_0.jpg GRAPHIC 16316
  Complete submission text file 0000950170-22-008469.txt   518583

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT enta-20220509_pre.xml EX-101.PRE 9896
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT enta-20220509.xsd EX-101.SCH 2481
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT enta-20220509_lab.xml EX-101.LAB 13466
8 EXTRACTED XBRL INSTANCE DOCUMENT enta-20220509_htm.xml XML 4757
Mailing Address 500 ARSENAL STREET WATERTOWN MA 02472
Business Address 500 ARSENAL STREET WATERTOWN MA 02472 617 607 0800
ENANTA PHARMACEUTICALS INC (Filer) CIK: 0001177648 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 001-35839 | Film No.: 22904769
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences